Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

That is not the case here, as you will see below. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter. Novo Nordisk ... pre-filled pen and Rybelsus ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access.

Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued ...

In 2020, the FDA expanded Ozempic’s use case to include approval ... for Ozempic is $968.52 per pen without insurance. While this drug can be expensive, Novo Nordisk offers a savings card ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

You can also visit the website for Novo Nordisk (the manufacturer of Ozempic ... Some insurance plans will require prior authorization to consider covering Ozempic. In this case, your healthcare ...